Log in

CVE:SCYBScythian Biosciences Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume231,491 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Scythian Biosciences Corp. engages in the research and development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury. It also develops drug candidates for the treatment of gastro-intestinal inflammatory issues. The company is headquartered in Toronto, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-416-3669192

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive SCYB News and Ratings via Email

Sign-up to receive the latest news and ratings for SCYB and its competitors with MarketBeat's FREE daily newsletter.

Scythian Biosciences (CVE:SCYB) Frequently Asked Questions

Has Scythian Biosciences been receiving favorable news coverage?

Media stories about SCYB stock have been trending somewhat negative on Saturday, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Scythian Biosciences earned a media sentiment score of -1.6 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutScythian Biosciences.

Who are some of Scythian Biosciences' key competitors?

What other stocks do shareholders of Scythian Biosciences own?

Who are Scythian Biosciences' key executives?

Scythian Biosciences' management team includes the following people:
  • Mr. Rob Reid, CEO & Director
  • Mr. Jonathan James Held, Chief Financial Officer (Age 32)
  • Mr. Maghsoud Dariani, Chief Scientific Officer (Age 65)
  • Prof. Michael Barnes, Chief Medical Officer

What is Scythian Biosciences' stock symbol?

Scythian Biosciences trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SCYB."

How do I buy shares of Scythian Biosciences?

Shares of SCYB and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Scythian Biosciences' official website?

The official website for Scythian Biosciences is scythianbio.com.

How can I contact Scythian Biosciences?

Scythian Biosciences' mailing address is 366 Bay St Suite 200, TORONTO, ON M5H 4B2, Canada. The company can be reached via phone at +1-416-3669192.

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.